195 related articles for article (PubMed ID: 31483918)
1. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
Raja E; Komuro A; Tanabe R; Sakai S; Ino Y; Saito N; Todo T; Morikawa M; Aburatani H; Koinuma D; Iwata C; Miyazono K
Oncogene; 2017 Aug; 36(35):4963-4974. PubMed ID: 28459464
[TBL] [Abstract][Full Text] [Related]
3. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.
Shirai YT; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
Am J Pathol; 2011 Dec; 179(6):2920-30. PubMed ID: 21996676
[TBL] [Abstract][Full Text] [Related]
6. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
7. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.
Liu S; Yin F; Fan W; Wang S; Guo XR; Zhang JN; Tian ZM; Fan M
J Exp Clin Cancer Res; 2012 May; 31(1):52. PubMed ID: 22650359
[TBL] [Abstract][Full Text] [Related]
9. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect.
Hallahan AR; Pritchard JI; Chandraratna RA; Ellenbogen RG; Geyer JR; Overland RP; Strand AD; Tapscott SJ; Olson JM
Nat Med; 2003 Aug; 9(8):1033-8. PubMed ID: 12872164
[TBL] [Abstract][Full Text] [Related]
11. Basal expression of bone morphogenetic protein receptor is reduced in mild asthma.
Kariyawasam HH; Xanthou G; Barkans J; Aizen M; Kay AB; Robinson DS
Am J Respir Crit Care Med; 2008 May; 177(10):1074-81. PubMed ID: 18292470
[TBL] [Abstract][Full Text] [Related]
12. Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk
Benn A; Hiepen C; Osterland M; Schütte C; Zwijsen A; Knaus P
FASEB J; 2017 Nov; 31(11):4720-4733. PubMed ID: 28733457
[TBL] [Abstract][Full Text] [Related]
13. Snail depletes the tumorigenic potential of glioblastoma.
Savary K; Caglayan D; Caja L; Tzavlaki K; Bin Nayeem S; Bergström T; Jiang Y; Uhrbom L; Forsberg-Nilsson K; Westermark B; Heldin CH; Ferletta M; Moustakas A
Oncogene; 2013 Nov; 32(47):5409-20. PubMed ID: 23524585
[TBL] [Abstract][Full Text] [Related]
14. Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway.
Jin X; Nie E; Zhou X; Zeng A; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y
Cell Physiol Biochem; 2017; 44(4):1616-1628. PubMed ID: 29212066
[TBL] [Abstract][Full Text] [Related]
15. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
Hasan T; Caragher SP; Shireman JM; Park CH; Atashi F; Baisiwala S; Lee G; Guo D; Wang JY; Dey M; Wu M; Lesniak MS; Horbinski CM; James CD; Ahmed AU
Cell Death Dis; 2019 Mar; 10(4):292. PubMed ID: 30926789
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival.
Duggal R; Geissinger U; Zhang Q; Aguilar J; Chen NG; Binda E; Vescovi AL; Szalay AA
J Transl Med; 2013 Jun; 11():155. PubMed ID: 23800258
[TBL] [Abstract][Full Text] [Related]
18. EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.
Li S; Ma Y; Xie C; Wu Z; Kang Z; Fang Z; Su B; Guan M
Oncotarget; 2015 Sep; 6(26):22587-97. PubMed ID: 26041887
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma.
Hover LD; Owens P; Munden AL; Wang J; Chambless LB; Hopkins CR; Hong CC; Moses HL; Abel TW
Neuro Oncol; 2016 Jul; 18(7):928-38. PubMed ID: 26683138
[TBL] [Abstract][Full Text] [Related]
20. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.
Yang S; Pham LK; Liao CP; Frenkel B; Reddi AH; Roy-Burman P
Cancer Res; 2008 Jan; 68(1):198-205. PubMed ID: 18172312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
